Weighted Average Number of Shares Outstanding, Diluted of FIBROGEN INC from Q2 2014 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Fibrogen Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q2 2014 to Q3 2025.
  • Fibrogen Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 4.04M shares, a 0.57% increase year-over-year.
  • Fibrogen Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 100M shares, a 2.82% increase from 2023.
  • Fibrogen Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 97.3M shares, a 3.98% increase from 2022.
  • Fibrogen Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 93.6M shares, a 1.34% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

FIBROGEN INC Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 4.04M +23K +0.57% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 4.04M +49K +1.23% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 101M +1.97M +1.99% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025
Q4 2024 100M +2.74M +2.82% 01 Oct 2024 31 Dec 2024 10-K 17 Mar 2025
Q3 2024 4.02M -94.2M -95.9% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 3.99M -93.7M -95.9% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 99M +4.29M +4.53% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025
Q4 2023 97.3M +3.72M +3.98% 01 Oct 2023 31 Dec 2023 10-K 17 Mar 2025
Q3 2023 98.2M +4.48M +4.78% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 97.7M +4.25M +4.55% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 94.7M +1.65M +1.77% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024
Q4 2022 93.6M 01 Oct 2022 31 Dec 2022 10-K 26 Feb 2024
Q3 2022 93.8M +959K +1.03% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023
Q2 2022 93.5M +1.2M +1.3% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 93M 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023
Q3 2021 92.8M -870K -0.93% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 92.3M +2.83M +3.16% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q3 2020 93.7M +6.67M +7.67% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 89.5M -2.28M -2.48% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2020
Q3 2019 87M +2.5M +2.96% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020
Q2 2019 91.7M +7.98M +9.53% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q3 2018 84.5M 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 83.8M +14.1M +20.3% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019
Q2 2017 69.6M +616K +0.89% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2017
Q2 2016 69M +270K +0.39% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017
Q2 2015 68.8M +31.6M +85.3% 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016
Q2 2014 37.1M 01 Apr 2014 30 Jun 2014 10-Q 13 Aug 2015

FIBROGEN INC Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 100M +2.74M +2.82% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025
2023 97.3M +3.72M +3.98% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025
2022 93.6M +1.23M +1.34% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2024
2021 92.3M +2.5M +2.78% 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024
2020 89.9M 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.